Neuralink, Elon Musk's brain-implant company, announced on Thursday that it has received approval from the Food and Drug Administration (FDA) to commence the first-ever clinical study involving humans.
Since 2019, Elon Musk, the billionaire, has repeatedly anticipated that his brain-chip company would soon obtain FDA approval for human trials. However,